GC Genome Corporation (KOSDAQ:340450)

GC Genome Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	160,116	161,298	-	-	-	-
Enterprise Value	124,017	124,035	-	-	-	-
Last Close Price	6770.00	6820.00	-	-	-	-
PE Ratio	36.68	39.88	-	-	-	-
PS Ratio	5.08	5.12	-	-	-	-
PB Ratio	2.05	2.06	-	-	-	-
P/TBV Ratio	2.06	2.08	-	-	-	-
P/FCF Ratio	162.46	163.66	-	-	-	-
P/OCF Ratio	123.46	124.37	-	-	-	-
EV/Sales Ratio	3.93	3.93	-	-	-	-
EV/EBITDA Ratio	26.63	30.23	-	-	-	-
EV/EBIT Ratio	69.32	100.38	-	-	-	-
EV/FCF Ratio	125.83	125.85	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.14	0.47	0.40	0.74
Debt / EBITDA Ratio	0.98	0.98	2.35	3.18	-	-
Debt / FCF Ratio	4.08	4.08	94.54	-	-	-
Net Debt / Equity Ratio	-0.46	-0.46	-0.06	0.13	-0.26	-0.61
Net Debt / EBITDA Ratio	-8.80	-8.80	-0.93	0.84	16.39	224.25
Net Debt / FCF Ratio	-36.63	-36.63	-37.60	-0.77	1.25	3.96
Asset Turnover	0.50	0.50	0.62	0.60	0.53	0.44
Inventory Turnover	10.51	10.51	11.96	11.56	14.85	-
Quick Ratio	17.67	17.67	3.74	1.00	2.13	6.26
Current Ratio	18.59	18.59	4.27	1.12	2.32	6.42
Return on Equity (ROE)	7.26%	7.26%	-4.32%	-2.13%	-16.52%	1.56%
Return on Assets (ROA)	1.23%	1.23%	-1.85%	0.22%	-4.43%	-3.13%
Return on Invested Capital (ROIC)	3.01%	3.28%	-4.15%	0.67%	-24.07%	-34.01%
Return on Capital Employed (ROCE)	1.50%	1.50%	-3.30%	0.50%	-8.40%	-5.60%
Earnings Yield	2.53%	2.51%	-	-	-	-
FCF Yield	0.62%	0.61%	-	-	-	-
Buyback Yield / Dilution	-20.29%	-20.29%	0.66%	-13.53%	-0.97%	10.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.